Pharma Journalist - Page 127 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Cytiva strengthens cell line development with CEVEC acquisition

CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine

Intravacc awarded US$14.6 Million NIH/NIAID contract to develop intranasal gonorrhea vaccine

BioLink Life Sciences, Charak Foundation and KARE Biosciences Announce contract for developing a novel treatment of COVID pneumonia and prevention of long COVID

Pfizer Completes Acquisition of Global Blood Therapeutics

Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine

Myonex Completes Acquisition of Hubertus Clinical Trial and Packaging Business

Almac unveils new Cryogenic Service Solution for advanced therapy trials

Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)